Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy

MLA

Chance S. Friesen, et al. “Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy.” Frontiers in Endocrinology, vol. 12, Apr. 2021. EBSCOhost, https://doi.org/10.3389/fendo.2021.663351.

APA

Chance S. Friesen, Chelsea Hosey-Cojocari, Sherwin S. Chan, Iván L. Csanaky, Jonathan B. Wagner, Brooke R. Sweeney, Alec Friesen, Jason D. Fraser, & Valentina Shakhnovich. (2021). Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.663351

Chicago

Chance S. Friesen, Chelsea Hosey-Cojocari, Sherwin S. Chan, Iván L. Csanaky, Jonathan B. Wagner, Brooke R. Sweeney, Alec Friesen, Jason D. Fraser, and Valentina Shakhnovich. 2021. “Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy.” Frontiers in Endocrinology 12 (April). doi:10.3389/fendo.2021.663351.